Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Ocd Clinical Trials

100 recruiting trials for Ocd. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
100
Total Trials
100
Recruiting Now
1
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT06624137

Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics

This is an observational study which does NOT directly administer a psychedelic substance but rather recruits participants who are already participating in another clinical trial...

Sponsor: Yale UniversityEnrolling: 2002 locations
RECRUITINGNCT04982757

Accelerated TMS for Depression and OCD

Repetitive transcranial magnetic stimulation (rTMS) is a FDA-approved treatment for depression and Obsessive Compulsive Disorder (OCD). The goal of the study is to learn how to...

Sponsor: Weill Medical College of Cornell UniversityEnrolling: 5001 location
RECRUITINGNCT06347978

Personalized DBS for OCD Guided by Stereoencephalography Mapping

This is a double-blinded, randomized, crossover study design for SEEG-guided 4-lead DBS for treatment-refractory OCD, followed by open label stimulation for an additional 6...

Sponsor: Andrew Moses Lee, MD, PhDEnrolling: 101 location
RECRUITINGNCT06978452

Behavioural Development, Long-term Outcomes and Opportunities to Optimize Youth Mental Health Trajectories

Behavioural Development, Long-term Outcomes and Opportunities to Optimize Youth Mental Health (BLOOM) is a project that aims to overcome age and diagnostic boundaries to generate...

Sponsor: Douglas Mental Health University InstituteEnrolling: 5601 location
RECRUITINGNCT07224126

Technology Assisted Treatment of Trichotillomania: Open Trial

This open-label feasibility trial evaluates the use of the Keen2 awareness bracelet for adults with trichotillomania (hair-pulling disorder). Participants will use the bracelet...

Sponsor: HabitAware Inc.Enrolling: 101 location
RECRUITINGNCT06942559

Brain-Oscillation Synchronized Stimulation of the DMPFC

This trial aims to obtain initial evidence about the clinical efficacy and modulation of neurophysiological markers in obsessive compulsive disorder (OCD) using personalized...

Sponsor: Centre for Addiction and Mental HealthEnrolling: 481 location
RECRUITINGNCT06929533

Pharmacogenomics-Supported Psychotropic Prescribing Trial

Investigate the feasibility and utility of implementing pharmacogenetic testing for adults (aged 18 and older) seeking care for mental illness in Manitoba.

Sponsor: University of ManitobaEnrolling: 2002 locations
RECRUITINGNCT07082777

Recovery in Telling Life Stories

This project tests the Recovery In Telling Life Stories (RETELL) intervention, aimed at supporting personal recovery in people with severe mental illness (SMI). While many of...

Sponsor: University of AarhusEnrolling: 201 location
RECRUITINGNCT06917339

Retrospective Analyses of TrakStar Database

In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar...

Sponsor: NeuroneticsEnrolling: 1560001 location
RECRUITINGPhase 2NCT05783817

MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)

The study assesses the safety and preliminary effectiveness of MDMA-assisted cognitive behavioral therapy in participants diagnosed with obsessive-compulsive disorder (OCD).

Sponsor: Carolyn RodriguezEnrolling: 401 location
RECRUITINGPhase 3NCT05331937

TMS for Exposure Therapy Resistant OCD

TETRO is a multi-center placebo-controlled double-blind randomized controlled trial with an intervention phase of 5-7 weeks and a follow-up phase of 12 months in 250 adult (18...

Sponsor: Amsterdam UMC, location VUmcEnrolling: 2508 locations
RECRUITINGNCT07483021

Detection of Hoarding Disorder and Related Psychopathology

Hoarding disorder is characterized by excessive amassment of objects in the home and difficulty of getting rid of the objects. It is associated with a high level of somatic and...

Sponsor: Andreas Rosén RasmussenEnrolling: 601 location
RECRUITINGNCT05237466

Motivational Interviewing to Enhance Behavioral Change in Older Adults with Hoarding Disorder

This study will compare two behavioral interventions for hoarding disorder in older adults.

Sponsor: Mississippi State UniversityEnrolling: 601 location
RECRUITINGNCT04958096

Cortical Stimulation to Treat Obsessive Compulsive Disorder

The purpose of this study is to identify abnormal brain signals associated with Obsessive Compulsive Disorder (OCD) and psychiatric symptoms and to investigate novel therapeutic...

Sponsor: Andrew Moses Lee, MD, PhDEnrolling: 151 location
RECRUITINGNCT07255131

The Effectiveness and Efficacy of an Online Cognitive Behavioral Psychotherapeutic Program

An online group cognitive behavioral psychotherapeutic program will be offered to patients with cystic fibrosis and to caregivers by the Hellenic Cystic Fibrosis Association....

Sponsor: Rakitzi, StavroulaEnrolling: 521 location
RECRUITINGNCT05580614

Paired tVNS With ERP in OCD

In the proposed investigation, the investigator will develop pilot data for the use of tVNS (transcutaneous vagal nerve stimulation) to enhance efficacy of exposure and response...

Sponsor: University of FloridaEnrolling: 561 location
RECRUITINGNCT05609916

CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD

The purpose of this study is to examine whether youth with OCD who benefit from CBT augmentation to SRI can discontinue their medication without relapse over 24 weeks.

Sponsor: Baylor College of MedicineEnrolling: 2001 location
RECRUITINGNCT06941155

Gamified Combined Cognitive Bias Modification in Adults Diagnosed With OCD: Randomized Controlled Trial

This randomized controlled trial examines the effects of a mobile-based gamified combined cognitive bias modification (CBM-C) intervention on obsessive-compulsive symptoms,...

Sponsor: Dokuz Eylul UniversityEnrolling: 901 location
RECRUITINGNCT06407648

Using Personalized Assessments in the Treatment of Childhood OCD

The primary purpose of this study is to learn whether personalized assessment of obsessive-compulsive disorder (OCD) symptoms in childhood OCD using mobile health technology are...

Sponsor: Johns Hopkins UniversityEnrolling: 301 location
RECRUITINGNCT05577585

Ketamine in OCD: Efficacy and Effects on Stress and Cognition

The main goal of this trial is to demonstrate therapeutic efficacy of low dose ketamine in patients with OCD. We expect that ketamine will alleviate symptoms in the hours...

Sponsor: Medical University of ViennaEnrolling: 601 location
RECRUITINGNCT07484750

Efficacy and Influencing Factors of Mindfulness-Based Exposure Group Therapy for OCD

Obessive-Compulsive Disorder (OCD) is frequently treatment-refractory and imposes a substantial burden on affected individuals. Although Exposure and Response Prevention (ERP) is...

Sponsor: Shanghai Mental Health CenterEnrolling: 641 location
RECRUITINGNCT06017713

tDCS Associated With Symptom Provocation in the Management of Patients With Resistant Obsessive Compulsive Disorder

This is a single-center study about patients with severe resistant OCD. Main assumption is that performing 10 tDCS sessions with the anode positioned at the level of the right...

Sponsor: Centre Hospitalier Henri LaboritEnrolling: 251 location
RECRUITINGNCT07558148

OCD LIFU Target Engagement

The investigators will conduct a pilot study to evaluate the safety and feasibility of low-intensity focused ultrasound on obsessive-compulsive disorder (OCD) symptoms when...

Sponsor: University of PennsylvaniaEnrolling: 101 location
RECRUITINGNCT05995951

Deep Brain Stimulation Surgery for the Treatment of Refractory Obsessive-Compulsive Disorder

This study will include two parts. The first part will include two patients in a non-blinded, non-randomized, open trial. They will undergo Deep Bran Stimulation (DBS) for OCD...

Sponsor: Rabin Medical CenterEnrolling: 101 location
RECRUITINGNCT01635569

Clinical Outcomes in Pediatric Obsessive-Compulsive Disorder

Obsessive-Compulsive Disorder (OCD) is a common neuropsychiatric illness beginning in childhood. Effective OCD treatments include cognitive-behaviour therapy (CBT) and medications...

Sponsor: University of British ColumbiaEnrolling: 1801 location
RECRUITINGNCT07113652

The Efficacy of Temporal Interference Stimulation in the Treatment of Obsessive-Compulsive Disorder

This study aims to evaluate the efficacy of Temporal Interference (TI) stimulation in treating patients with obsessive-compulsive disorder (OCD) and to explore its potential...

Sponsor: Shanghai Mental Health CenterEnrolling: 181 location
RECRUITINGNCT06494735

Effect of the French Version If the Metagognitive Bibliotherapy Program "MYMCT" on Obsessive-compulsive Symptoms

Obsessive-compulsive disorder (OCD) is a psychiatric illness characterized by the presence of obsessions and/or compulsions. Without effective treatment, symptoms tend to worsen...

Sponsor: Centre Hospitalier Universitaire de NiceEnrolling: 1141 location
RECRUITINGNCT06692114

Efficacy and Influencing Factors of Deep Transcranial Magnetic Stimulation in the Treatment of OCD

This study aims to explore the efficacy and influencing of accelerated dTMS (deep Transcranial Magnetic Stimulation) treatment in patients with obsessive-compulsive disorder...

Sponsor: Zhen WangEnrolling: 701 location
RECRUITINGNCT04730011

Short and Intensive Treatment of Children and Adolescents With Obsessive-Compulsive Disorder

Obsessive-compulsive disorders are very damaging illnesses; they can already appear in childhood and adolescence and become extremely chronic. With an average prevalence from...

Sponsor: Susanne WalitzaEnrolling: 1001 location
RECRUITINGNCT06542224

Identifying Local Field Potential Biomarkers for Obsessive-compulsive Disorder Treatment With Deep Brain Stimulation

Obsessive-compulsive disorder (OCD) is a complex and severe mental illness characterized by multiple symptoms and is considered a leading cause of non-fatal health loss. However,...

Sponsor: West China HospitalEnrolling: 164 locations
RECRUITINGNCT05623306

SEEG-Guided DBS for OCD

This is a multi-site, double-blinded, randomized, crossover study design for SEEG-guided 4-lead DBS for treatment-refractory OCD, followed by open label stimulation for an...

Sponsor: Katherine ScangosEnrolling: 102 locations
RECRUITINGNCT07232823

Brief Culturally Adapted CBT for OCD

The purpose aims to assess the efficacy of Brief Culturally Adapted Cognitive Behaviour Therapy (Ca-CBT) for the treatment of Obsessive Compulsive Disorder (OCD).

Sponsor: Pakistan Association of Cognitive TherapistsEnrolling: 1661 location
RECRUITINGNCT04725409

Neural Correlates of Psychiatric Disorders

This ClincialTrials.gov record originally corresponded to the protocol approved under IRB # 202370. The study was expanded to include stimulation and recordings approved under new...

Sponsor: Vanderbilt University Medical CenterEnrolling: 1001 location
RECRUITINGNCT06763081

Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation

The purpose of this study is to identify and validate a panel of genetic markers associated with selective serotonin reuptake inhibitors (SSRI)-induced behavioural activation in...

Sponsor: University of ManitobaEnrolling: 1602 locations
RECRUITINGNCT06647589

Acceptance and Commitment Therapy for Religious OCD

The purpose of the study is to examine the effects and feasibility of a specific form of psychotherapy, acceptance and commitment therapy (ACT), on religiously oriented obsessive...

Sponsor: University of Alabama at BirminghamEnrolling: 101 location
RECRUITINGPhase 2NCT04882839

Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe OCD

Obsessive-compulsive disorder (OCD) is a neuropsychiatric disorder characterized by recurrent distressing thoughts and substantial anxiety, accompanied by repetitive behaviors or...

Sponsor: Beersheva Mental Health CenterEnrolling: 151 location
RECRUITINGNCT07031544

Efficacy and Influencing Factors of ALIC-NAc Deep Brain Stimulation in Treatment-Refractory Obsessive-Compulsive...

The goal of this clinical trial is to evaluate the efficacy and influencing factors of the combination of the anterior limb of internal capsule and nucleus accumbens (ALIC-NAc)...

Sponsor: Shanghai Mental Health CenterEnrolling: 6010 locations
RECRUITINGNCT07245134

Virtual Reality Exposure Therapy for Obsessive-Compulsive Disorder: A Randomized Controlled Trial in Inpatients

The aim of this study is to evaluate the efficacy of virtual reality exposure therapy (VRET) as a treatment for obsessive-compulsive disorder (OCD). Participants are randomly...

Sponsor: National Institute of Mental Health, Czech RepublicEnrolling: 621 location
RECRUITINGNCT05577598

Glucose Consumption During Deep Brain Stimulation With Functional [18F]FDG-Brain-PET in Obsessive-Compulsive Disorder

The purpose of this randomized, sham-controlled study is to evaluate the effectiveness of DBS therapy in individuals suffering from severe OCD and to investigate DBS treatment...

Sponsor: Medical University of ViennaEnrolling: 81 location
RECRUITINGNCT06596447

Neurophysiological Investigation of the Approach-avoidance Axis in OCD: Applications to Neuromodulation

We will recruit 10 patients with OCD meeting established criteria for surgical evaluation. Following informed consent and baseline evaluations, each will be implanted with...

Sponsor: Baylor College of MedicineEnrolling: 102 locations
RECRUITINGNCT06944366

Comparing Exposure v Imagery Rescripting in People With OCD: a SCED

Individuals with OCD may experience intrusive future orientated thoughts and images, which are extremely distressing and interfering in life. This project aims to explore whether...

Sponsor: King's College LondonEnrolling: 101 location
RECRUITINGNCT05467683

CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy

Anxiety-, obsessive-compulsive and trauma- and stressor-related disorders reflect a significant public health problem. This study is designed to evaluate the predictive power of a...

Sponsor: University of Texas at AustinEnrolling: 6002 locations
RECRUITINGNCT06804525

LHC-CIDI-5 in Hong Kong

The World Health Organization Composite International Diagnostic Interview-5th (CIDI-5) is a standardized diagnostic tool used to assess the prevalence of mental and substance use...

Sponsor: The University of Hong KongEnrolling: 25001 location
RECRUITINGPhase 2NCT05940324

Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

The purpose of this study is to understand how ketamine works in the brain to bring about a reduction in OCD symptoms.

Sponsor: Stanford UniversityEnrolling: 1501 location
RECRUITINGNCT05359562

How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD

Studies show that hormones affect the brain's fear extinction network, which is relevant for therapy involving exposure and response prevention (EX/RP), a first-line treatment for...

Sponsor: University of PennsylvaniaEnrolling: 1202 locations
RECRUITINGNCT07206212

A Lifestyle Intervention to Reduce Cardiometabolic Risk Factors in Individuals With Obsessive-compulsive Disorder

The overall aim of this study is to evaluate the efficacy and cost-effectiveness of a lifestyle intervention to improve lifestyle habits and reduce cardiometabolic risk factors in...

Sponsor: Karolinska InstitutetEnrolling: 1081 location
RECRUITINGNCT06262464

An OCD Prevention Programme for at Risk Adults

The main purpose of this randomised clinical trial is to test the efficacy of a prevention program for adult who are at risk of developing OCD, thus constituting a form of...

Sponsor: Babes-Bolyai UniversityEnrolling: 2001 location
RECRUITINGNCT06834217

Transcranial Direct Current Stimulation and Extinction in Obsessive Compulsive Disorder

Obsessive-compulsive disorder (OCD) is associated with substantial impairments in quality of life and is among the most disabling psychiatric disorders. Exposure therapy is among...

Sponsor: Yale UniversityEnrolling: 1801 location
RECRUITINGNCT05332288

Triphasic Osteochondral Scaffold for the Treatment of the OCD of the Knee: Observational Study

The objective of the present study is to evaluate the clinical results of reconstructive treatment of knee OCD defects treated with osteochondral scaffolds implanted with specific...

Sponsor: Istituto Ortopedico RizzoliEnrolling: 301 location
RECRUITINGNCT06346301

Imagery Rescripting as a Stand-alone Treatment for OCD and BDD.

The goal of this multiple baseline case series study is to test the effect of imagery rescripting (ImRs) in Obsessive Compulsive Disorder (OCD) and Body Dysmorphic Disorder (BDD)....

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Enrolling: 361 location

Showing 50 of 100 trials.Search all Ocd trials

Frequently Asked Questions

There are currently 100 clinical trials for Ocd, with 100 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Ocd, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 1 Phase 3 trials for Ocd, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.

For this entity, the underlying data on this page comes from the NIH ClinicalTrials.gov registry. The breakdown above is the federal record; the paragraphs below add the per-entity context that makes the headline numbers usable for a real decision rather than just a data lookup.

The methodology behind every numeric value on this page is publicly documented on the the NIH ClinicalTrials.gov registry portal and described in detail on this site’s methodology page. Refresh cadence varies by underlying series; the page surfaces the as-of date for each number so readers can trace any figure back to the source release.

For readers using this page as a decision input, the related-entity pages elsewhere on the site provide the comparison set. The most useful comparison for this entity is typically a peer within active and historical clinical trials with similar size, similar exposure, or similar geography — not the national-level summary alone.